Team:Reading/Parts

From 2014.igem.org

(Difference between revisions)
 
(23 intermediate revisions not shown)
Line 1: Line 1:
{{Head}}
{{Head}}
-
 
+
<br><br><br><br><br><br><br><br><br><br>
-
 
+
<html>
<html>
<style type="text/css">
<style type="text/css">
Line 10: Line 9:
<!--Our parts-->
<!--Our parts-->
-
<tr><td><h3><font color="#558e2b"> Our parts </font></h3></td>
+
<h3 class="title"> Our parts</h3>
-
<td></td>
+
<tr> <td colspan="3"  height="10px"> </td></tr>
<tr> <td colspan="3"  height="10px"> </td></tr>
Line 28: Line 26:
method of plasmid construction. We will therefore submit all our BioBricks for
method of plasmid construction. We will therefore submit all our BioBricks for
insertions and deletions to the registry. All of these will contain Kanamycin
insertions and deletions to the registry. All of these will contain Kanamycin
-
resistance for selecting transformants.  
+
resistance for simple selection of transformants.  
 +
<br />
 +
<br />
 +
<center><img src="https://static.igem.org/mediawiki/2014/6/6c/Matt_bg11plate_1.jpg" width=600px></center>
 +
<br />
 +
<center>Above: Wild-type <i>Synechocystis</i> transformed with a plasmid carrying kanamycin resistance.</center>
<br />
<br />
<br />
<br />
The mechanism for each of the BioBricks is the same. They will undergo
The mechanism for each of the BioBricks is the same. They will undergo
recombination with the region that they share homology with. Knockouts will
recombination with the region that they share homology with. Knockouts will
-
undergo recombination with the specified gene, repl
+
undergo recombination with the specified gene, replacing it with kanamycin resistance. Insertions will undergo recombination with a region of the
-
acing it will kanamycin resistance. Insertions will undergo recombination with a region of the
+
chromosome that is not important for the metabolic
chromosome that is not important for the metabolic
-
conditions we are using, and will insert the gene of interest and a kanamycin resistance gene.  
+
conditions we are using, and will insert the gene of interest along with a kanamycin resistance gene.  
<br />
<br />
<br />
<br />
-
We are creating 7 BioBricks that will be submitted
+
We are creating 4 BioBricks that will be submitted
-
to registry, consisting of 4
+
to registry, consisting of 2
-
deletions and 3 insertions, in addition to improving characterization of an
+
deletions (<a href="http://parts.igem.org/Part:BBa_K1476003" title="Go to PsaD wiki page">PsaD</a> and <a href="http://parts.igem.org/Part:BBa_K1476000" title="Go to PilT1 wiki page">PilT1</a>) and 2 insertions (<a href="http://parts.igem.org/Part:BBa_K1476004" title="Go to PetF wiki page">PetF</a> and <a href="http://parts.igem.org/Part:BBa_K1476001" title="Go to PilA1 wiki Page">PilA1</a>). Background information on the aim of these parts can be
-
existing BioBrick. Background information on the aim of these parts can be
+
found in our <a href="https://2014.igem.org/Team:Reading/Project" title="Go to project section">project section</a>. <br />
-
found in our <a href="https://2014.igem.org/Team:Reading/Project" title="Go To Project Section">project section</a> .  
+
<br />
-
 
+
<tr> <td colspan="3"  height="15px"> </td></tr>
<tr> <td colspan="3"  height="15px"> </td></tr>
-
<tr><td><h3><font color="#558e2b"> Reading iGEM 2014 parts </font></h3></td>
+
<tr><td><h3 class="title"> Reading iGEM 2014 parts</h3></td>
<td></td>
<td></td>

Latest revision as of 00:31, 18 October 2014

University of Reading
Home Team Project Fuel Cell Parts Human Practices Lab book Protocols Attributions










Our parts

Genetic modification in Synechocystis is done by modifying the chromosome, rather than inserting plasmids. Synechocystis is naturally transformable, and will undergo homologous recombination between its chromosome and a plasmid containing a homologous region. This means that plasmids for insertion or deletion need to have regions of ~500 to ~1000bp either side of the inserted sequence, making modifications time consuming or costly depending on your method of plasmid construction. We will therefore submit all our BioBricks for insertions and deletions to the registry. All of these will contain Kanamycin resistance for simple selection of transformants.


Above: Wild-type Synechocystis transformed with a plasmid carrying kanamycin resistance.


The mechanism for each of the BioBricks is the same. They will undergo recombination with the region that they share homology with. Knockouts will undergo recombination with the specified gene, replacing it with kanamycin resistance. Insertions will undergo recombination with a region of the chromosome that is not important for the metabolic conditions we are using, and will insert the gene of interest along with a kanamycin resistance gene.

We are creating 4 BioBricks that will be submitted to registry, consisting of 2 deletions (PsaD and PilT1) and 2 insertions (PetF and PilA1). Background information on the aim of these parts can be found in our project section.

Reading iGEM 2014 parts

<groupparts>iGEM013 Reading</groupparts>

Facebook
Twitter
rusynbioigem@gmail.com

Retrieved from "http://2014.igem.org/Team:Reading/Parts"